// App-Quantinova.ai

9090 : Association between improvements in survival of metastatic NSCLC patients and targeted- and immuno-therapy.

Researchers

Presenter

  • Sreeram Ramagopalan

Principal Investigators

  • Thomas P. Leahy

  • Joshua Ray

  • Samantha Wilkinson

  • Cormac J. Sammon

  • Vivek Subbiah

Medical Centers

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • PHMR, Westport, Ireland

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • Switzerland

  • Ireland

  • United Kingdom

  • United States

Companies

  • F. Hoffmann-La Roche

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • B-Raf proto-oncogene, serine/threonine kinase

  • Proto-oncogene tyrosine-protein kinase ROS

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved